Trademark Overview
On Wednesday, July 2, 2025, a trademark application was filed for RETYPPI with the United States Patent and Trademark Office. The USPTO has given the RETYPPI trademark a serial number of 99264717. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 2, 2025. This trademark is owned by Tern Therapeutics, LLC. The RETYPPI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for gene therapy for the treatment of neurodegenerative and ocular disorders; Pharmaceutical preparations for gene therapy for the treatment of Neuronal Ceroid Lipofuscinosis Type 2; Pharmaceutical preparations for gene therapy for the treatment of genetic disorders